UK-wide antiviral clinical trial platform in non-hospitalised patients
NIHR are seeking to fund a research consortium to deliver a complex community-based clinical trial platform for antiviral candidates for COVID-19 that could augment the current vaccine and therapeutic programmes.
Due to the urgency of this research applications will be fast-tracked. Applicants will be asked to complete a stage 2 application and there will be a one stage assessment process. Timelines for submitting the proposal will also be very tight. – deadline 13.00 on 17th August.
For all the information on how to apply please see the NIHR webpage.